Research / ITP / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-21-017307 General Corporate
Debt relative to revenue 21th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.debt_to_revenue
9.50% · OPTIONAL · VALID
Capex intensity 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
20.91% · OPTIONAL · VALID
Operating cash generation 74th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.99% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=15
Evidence method Yoy · gp.fundamentals.revenue
-14.17% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
1.22% · OPTIONAL · VALID
Gross margin 21th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
5.65% · CORE · VALID
Operating margin 26th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.operating_margin
-5.40% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.07% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.24% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Dec 31, 2020 7/9 normalized Amended as filed Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 27.56%
Current 9.50%
Delta -18.05% Capex Intensity Increased
Previous 6.48%
Current 20.91%
Delta 14.42% Cash Generation Increased
Previous -10.45%
Current 15.99%
Delta 26.45% Growth Decreased
Previous 1.27%
Current -14.17%
Delta -15.45% Inventory Pressure Decreased
Previous 25.73%
Current 1.22%
Delta -24.51% Margin Decreased
Previous 7.70%
Current 5.65%
Delta -2.05% Profitability Decreased
Previous 0.53%
Current -5.40%
Delta -5.93% Sbc Intensity Increased
Previous 0.00%
Current 1.24%
Delta 1.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.